Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction

Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction

Aim. To determine the concentration of the stimulating growth factor ST2 and its relationship to the clinical course of myocardial infarction (MI) over time during hospitalization. Subjects and methods. Eighty-eight MI patients whose mean age was 59±8.36 years were examined. On days 1 and 12 of MI,...

Full description

Bibliographic Details
Main Authors:	O V Gruzdeva, O E Akbasheva, E G Uchasova, Yu A Dyleva, N V Fedorova, V N Karetnikova, V V Kashtalap, O L Barbarash
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2016-04-01
Series:	Терапевтический архив
Subjects:	myocardial infarction hospitalization stimulating growth factor st2 n-terminal pro-brain natriuretic peptide (nt-probnp)
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/31952/pdf

Similar Items

Role of N-terminal pro-B-type natriuretic peptide in the prediction of outcomes in ST-elevation myocardial infarction complicated by cardiogenic shock
by: Yash Paul Sharma, et al.
Published: (2020-07-01)

Serum and Echocardiographic Markers May Synergistically Predict Adverse Cardiac Remodeling after ST-Segment Elevation Myocardial Infarction in Patients with Preserved Ejection Fraction
by: Tamara Pecherina, et al.
Published: (2020-05-01)

Analysis of distant cardiovascular events depending on the biomarker profile in patients with myocardial infarction
by: A. F. Khamitova, et al.
Published: (2019-04-01)

BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
by: N V Shilyaeva, et al.
Published: (2018-03-01)

RELATION OF THE MARKERS OF MYOCARDIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION WITH STRUCTURAL AND FUNCTIONAL PARAMETERS OF THE LUNGS IN MYOCARDIAL INFARCTION PATIENTS
by: O. M. Polikutina, et al.
Published: (2018-04-01)

N-terminal natriuretic propeptide type-b (NT-proBNP) and left ventricular ejection fraction in acute phase of st-segment elevation myocardial infarction and 1-year later
by: Jernej Markež, et al.
Published: (2007-11-01)

Kadar N-Terminal Pro-Brain Natriuretic Peptide sebagai Prediktor Luaran Klinis Sindrom Koroner Akut
by: Florencia Idajanti Tandhana, et al.
Published: (2012-06-01)

A Clinical Study of the N-Terminal pro-Brain Natriuretic Peptide in Myocardial Injury after Neonatal Asphyxia
by: Rui Zhu, et al.
Published: (2016-04-01)

N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity
by: F. Fernandes, et al.
Published: (2007-02-01)

Relationship between renalase and N-terminal pro-B-type Natriuretic Peptide (NT pro-BNP) in haemodialysis patients
by: Marcin Dziedzic, et al.
Published: (2014-03-01)

Can Fetuin A Be Utilized in the Evaluation of Elderly Patients with Acute Myocardial Infarction?
by: Raluca Tomoaia, et al.
Published: (2021-09-01)

Risk prediction in acute coronary syndrome depending on the types of myocard revascularization
by: R. V. Denina
Published: (2016-12-01)

N-TERMINAL BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2012-06-01)

The Indian Consensus Document on cardiac biomarker
by: I. Satyamurthy, et al.
Published: (2014-01-01)

Clinical roles of soluble ST2 for the outcomes of cardiac valve operations
by: Robert Chen
Published: (2016-04-01)

A MULTI-MARKER MODEL FOR PREDICTING DECOMPENSATED HEART FAILURE IN PATIENTS WITH PRIOR ACUTE MYOCARDIAL INFARCTION
by: Khrystyna Levandovska
Published: (2020-02-01)

Natriuretic peptides: Diagnostic and therapeutic use
by: Kaushik Pandit, et al.
Published: (2011-01-01)

Association of 25-hydroxyvitamin D deficiency with NT-pro BNP levels in patients with acute myocardial infarction: a cross-sectional analysis
by: Wetmore James B, et al.
Published: (2011-12-01)

ANALYSIS OF CHANGE IN NT-proBNP AFTER ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY IN PATIENT WITH HEART FAILURE
by: Intan Kusuma Dewi, et al.
Published: (2017-08-01)

CRP, NT-proBNP, CK-MB, cTnT level and clinical significance in patients with acute myocardial infarction before and after PCI
by: Yang-Zhen Zhou, et al.
Published: (2016-07-01)

INSULIN RESISTANCE MARKERS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2011-12-01)

Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
by: Gruzdeva O, et al.
Published: (2017-12-01)

Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
by: Wei Pan, et al.
Published: (2020-04-01)

Predictors of secondary cardiovascular events
by: Dallmeier Rojas, Dhayana Elizabeth
Published: (2016)

Association between vitamin D levels and left ventricular function and NT-proBNP levels among thalassemia major children with iron overload
by: Leny Ambarwati, et al.
Published: (2016-01-01)

The guiding evidence based therapy using biomarker intensified treatment in heart failure (GUIDE-IT) study; the utility of decongestive diuresis in type 1 cardiorenal syndrome with rising pro-BNP levels
by: Macaulay Amechi Chukwukadibia Onuigbo
Published: (2018-05-01)

Chronic heart failure in the practice of the therapist: is it difficult to recognize it?
by: Andrey A. Kirichenko, et al.
Published: (2019-01-01)

ANALYSIS OF CHANGES IN THE SERUM LEVEL NT-proBNP AFTER ACE INHIBITORS THERAPY IN PATIENTS WITH HEART FAILURE
by: Halla Hisan Hartoto, et al.
Published: (2017-08-01)

Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain
by: Stefanie Reynen, et al.
Published: (2021-06-01)

Pro-inflammatory cytokines and depression in myocardial infarction
by: O. L. Barbarash, et al.
Published: (2011-04-01)

Diagnostic value of NT–PRO BNP in cardiogenic and non cardiogenic pleural effusions
by: Mohamed E. Abdalla, et al.
Published: (2012-07-01)

Predictive markers of atrial fibrillation in patients after acute ST-elevated myocardial infarction (the results of observational program “FAKEL”)
by: I. A. Zolotovskaya, et al.
Published: (2018-10-01)

Effect of spironolactone on transmitral diastolic blood flow and course of chronic heart failure with preserved left ventricular ejection fraction
by: V. A. Vasylenko
Published: (2015-10-01)

NT-proBNP in Isolated Diastolic Dysfunction
by: Kenan İltümür, et al.
Published: (2005-01-01)

Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patients
by: Thomas Schachner, et al.
Published: (2010-01-01)

BNP und NT-proBNP als Biomarker zur Detektion von paroxysmalem Vorhofflimmern bei Patienten mit kardiovaskulären Risikofaktoren
by: Grüter, Timo
Published: (2014)

Diagnosing heart failure in primary care: individual patient data meta‐analysis of two European prospective studies
by: Andrea K. Roalfe, et al.
Published: (2021-06-01)

The minimal informative monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure
by: Zhehao Dai, et al.
Published: (2020-06-01)

The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study
by: J. Kutsch, et al.
Published: (2018-01-01)

Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores
by: Schellings DAAM, et al.
Published: (2016-11-01)